Can I read Seladelpar in Primary Biliary Cholangitis on EtoBox?

Seladelpar in Primary Biliary Cholangitis by 2dtphw6qpc is a document available to read on EtoBox.

What is Seladelpar in Primary Biliary Cholangitis about?

The document discusses the ongoing ASSURE trial evaluating Seladelpar, a selective PPARδ agonist, for treating Primary Biliary Cholangitis (PBC), a chronic liver disease. Results indicate that Seladelpar shows significant biochemical responses and sustained improvement in pruritus symptoms over a 30-month period, with a favorable safety profile. The findings suggest Seladelpar as a valuable treatment option for patients with inadequate response to standard therapies like Ursodeoxycholic acid.

Author

2dtphw6qpc

Language

EN